Albumin-fused kunitz domain peptides

Details for Australian Patent Application No. 2003210885 (hide)

International Classifications

Event Publications

17 July 2003 Complete Application Filed

Priority application(s): 60/355,547 07.02.02 US

25 September 2003 Application Open to Public Inspection

Published as AU-B-2003210885

7 October 2004 Assignment before Grant

Aventis Behring GmbH; Dyax Corporation; Aventis Behring L. L. C.; Delta Biotechnology Limited The application has been assigned to Delta Biotechnology Limited; Dyax Corporation

4 November 2004 Amendment Made

The nature of the amendment is: Amend the name of the co-applicant from Dyax Corporation to Dyax Corp.

21 December 2006 Change of Name(s) of Applicant(s), Section 104

Dyax Corp.; Delta Biotechnology Limited The name of the applicant has been changed to Dyax Corp.; Novozymes Delta Limited

21 May 2009 Alteration of Name

The name of the applicant has been altered to Dyax Corp.; Novozymes Biopharma UK Limited

4 June 2009 Application Accepted

Published as AU-B-2003210885

1 October 2009 Standard Patent Sealed

26 August 2010 Assignment Registered

Novozymes Biopharma UK Limited; Dyax Corp. The patent has been assigned to Dyax Corp.; Novozymes Biopharma DK A/S

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.